Insider Transactions in Q2 2025 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2025
|
Robert B Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+30.94%
|
-
|
|
May 15
2025
|
Gary M Pfeiffer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+3.77%
|
-
|
|
May 15
2025
|
Timothy M Ring Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+3.92%
|
-
|
|
May 15
2025
|
Wright Lassiter Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+11.75%
|
-
|
|
May 15
2025
|
Denise M Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+10.07%
|
-
|
|
May 15
2025
|
Timothy L Main Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+4.37%
|
-
|
|
May 15
2025
|
Tracey Doi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+15.64%
|
-
|
|
May 15
2025
|
Vicky B Gregg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+6.22%
|
-
|
|
May 15
2025
|
Luis Diaz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+22.88%
|
-
|
|
May 13
2025
|
Mark E Delaney SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
874
-10.44%
|
$152,950
$175.31 P/Share
|
|
May 12
2025
|
Mark E Delaney SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
874
-9.45%
|
$152,950
$175.72 P/Share
|
|
Apr 21
2025
|
Mark E Delaney SVP & Chief Commercial Officer |
BUY
Small Acquisition
|
Direct |
25
+0.27%
|
$4,100
$164.42 P/Share
|
|
Apr 21
2025
|
Vicky B Gregg Director |
BUY
Grant, award, or other acquisition
|
Direct |
68
+0.4%
|
$11,152
$164.42 P/Share
|
|
Apr 21
2025
|
Patrick Plewman SVP for Diagnostic Services |
BUY
Small Acquisition
|
Direct |
81
+0.38%
|
$13,284
$164.42 P/Share
|
|
Apr 21
2025
|
Karthik Kuppusamy SVP, Clinical Solutions |
BUY
Small Acquisition
|
Direct |
27
+0.25%
|
$4,428
$164.42 P/Share
|
|
Apr 21
2025
|
Sam Samad Executive Vice President & CFO |
BUY
Small Acquisition
|
Direct |
74
+0.28%
|
$12,136
$164.42 P/Share
|
|
Apr 02
2025
|
J. E. Davis CEO and President |
SELL
Open market or private sale
|
Direct |
39,191
-1.76%
|
$6,584,088
$168.74 P/Share
|
|
Apr 02
2025
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Open market or private sale
|
Direct |
2,555
-19.46%
|
$434,350
$170.0 P/Share
|